Question · Q1 2026
Alex Paris with Barrington Research inquired about the consolidated student starts, specifically the stronger growth in the UTI division versus flat growth in Concorde, and the impact of shifting marketing dollars to UTI adult and high school segments. He also asked for clarification on capital expenditure expectations for fiscal years 2026 and 2027.
Answer
CEO Jerome Grant confirmed that Q1 starts were in line with guidance, attributing Concorde's flat growth to a high comparable quarter last year and increased investment in UTI ahead of new campus launches. He noted strong initial enrollments for San Antonio and Atlanta. CFO Bruce Schuman added that UTI starts showed broad-based mid-single-digit growth across channels and reiterated the $100 million CapEx expectation for fiscal 2026, with a similar quantum expected for 2027, primarily for growth initiatives.
Ask follow-up questions
Fintool can predict
UTI's earnings beat/miss a week before the call